PMID- 37352811 OWN - NLM STAT- MEDLINE DCOM- 20230719 LR - 20230719 IS - 1879-1379 (Electronic) IS - 0022-3956 (Linking) VI - 164 DP - 2023 Aug TI - PAG neuronal NMDARs activation mediated morphine-induced hyperalgesia by HMGB1-TLR4 dependent microglial inflammation. PG - 150-161 LID - S0022-3956(23)00275-3 [pii] LID - 10.1016/j.jpsychires.2023.05.082 [doi] AB - Morphine is one of the most effective and widely used analgesic drugs. However, chronic morphine use caused opioid-induced hyperalgesia (OIH). The development of OIH limits the use of morphine. The mechanisms of OIH are not fully understood. Toll-like receptor4 (TLR4) and glutamate receptors in the periaqueductal gray (PAG) are critical in OIH, however, the association between TLR4 and N-methyl-D-aspartate Receptors (NMDARs) activation in PAG remains unclear. Microglia activation, increased TLR4/p65 nuclear factor-kappa B (p65 NF-kappaB) and proinflammatory cytokines in microglia, and phosphorylation of NMDAR1 subunit (NR1) and NMDAR2B subunit (NR2B) in neurons were observed in PAG of OIH mice. Up-regulations of TLR4/p65 NF-kappaB and proinflammatory cytokines (IL-1beta, IL-6, TNF-alpha) in BV2 cells were prevented by inhibiting and knocking down TLR4. By inhibiting myeloid differentiation factor 2 (MD2) and knocking down the High-mobility group box 1 (HMGB1), we found that morphine activated TLR4 by HMGB1 but not MD2. We co-cultured Neuro-2a (N2A) with BV2 microglial cell line and found that instead of directly phosphorylating NMDAR subunits, morphine increased the phosphorylation of NR1 and NR2B by inducing TLR4-mediated microglia inflammation. Knocking TLR4 out of PAG by Lentivirus-GFP-TLR4 shRNA reversed these changes and relieved OIH. Our findings suggested that the secretion of HMGB1 induced by morphine-activated TLR4 in microglia, and the proinflammatory factors released by activated microglia phosphorylated NR1 and NR2B of adjacent neurons, induced increased neuronal excitability. In conclusion, TLR4/NMDARs in PAG were involved in the development and maintenance of OIH and supported novel strategies for OIH treatment. CI - Copyright (c) 2023 Elsevier Ltd. All rights reserved. FAU - Mo, Jingjing AU - Mo J AD - Department of Neurology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China. FAU - Lu, Zijing AU - Lu Z AD - Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510510, Guangdong, China. FAU - Peng, Jialing AU - Peng J AD - Department of Neurology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China; Department of Neurology, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China. FAU - Li, Xiang-Pen AU - Li XP AD - Department of Neurology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China. FAU - Lan, Lihuan AU - Lan L AD - Department of Neurology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China. FAU - Wang, Hongxuan AU - Wang H AD - Department of Neurology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China. Electronic address: wanghx8@mail.sysu.edu.cn. FAU - Peng, Ying AU - Peng Y AD - Department of Neurology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510828, Guangdong, China. Electronic address: pengy2@mail.sysu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230615 PL - England TA - J Psychiatr Res JT - Journal of psychiatric research JID - 0376331 RN - 76I7G6D29C (Morphine) RN - 0 (NF-kappa B) RN - 0 (Toll-Like Receptor 4) RN - 0 (HMGB1 Protein) RN - 0 (Analgesics, Opioid) RN - 0 (Cytokines) SB - IM MH - Mice MH - Animals MH - *Morphine/adverse effects/metabolism MH - Hyperalgesia/chemically induced/metabolism MH - NF-kappa B/metabolism MH - Microglia/metabolism MH - Toll-Like Receptor 4/metabolism MH - Periaqueductal Gray/metabolism MH - Signal Transduction MH - *HMGB1 Protein/adverse effects/metabolism MH - Inflammation/chemically induced/metabolism MH - Analgesics, Opioid/adverse effects MH - Cytokines/metabolism MH - Neurons OTO - NOTNLM OT - Microglial OT - NMDAR OT - OIH OT - PAG OT - TLR4 COIS- Declaration of competing interest The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. EDAT- 2023/06/24 11:41 MHDA- 2023/07/19 06:43 CRDT- 2023/06/23 18:10 PHST- 2023/01/01 00:00 [received] PHST- 2023/04/25 00:00 [revised] PHST- 2023/05/30 00:00 [accepted] PHST- 2023/07/19 06:43 [medline] PHST- 2023/06/24 11:41 [pubmed] PHST- 2023/06/23 18:10 [entrez] AID - S0022-3956(23)00275-3 [pii] AID - 10.1016/j.jpsychires.2023.05.082 [doi] PST - ppublish SO - J Psychiatr Res. 2023 Aug;164:150-161. doi: 10.1016/j.jpsychires.2023.05.082. Epub 2023 Jun 15.